Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the stock.

Retractable Technologies Stock Down 5.4 %

Retractable Technologies stock opened at $1.06 on Tuesday. The firm has a 50 day simple moving average of $1.12 and a 200 day simple moving average of $1.15. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 1-year low of $0.87 and a 1-year high of $1.34. The firm has a market capitalization of $31.74 million, a price-to-earnings ratio of -4.08 and a beta of 2.08.

Retractable Technologies (NYSE:RVPGet Free Report) last released its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $7.60 million for the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%.

Insider Activity

In other Retractable Technologies news, CEO Thomas J. Shaw bought 48,635 shares of the firm’s stock in a transaction on Thursday, May 16th. The shares were acquired at an average cost of $1.03 per share, for a total transaction of $50,094.05. Following the purchase, the chief executive officer now directly owns 14,417,148 shares of the company’s stock, valued at $14,849,662.44. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders bought 155,281 shares of company stock worth $161,351 in the last three months. Corporate insiders own 55.00% of the company’s stock.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.